Shao Y - Search Results

1

CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.

Tang Q, Lu J, Zou C, Shao Y, Chen Y, Narala S, Fang H, Xu H, Wang J, Shen J, Khokha R. Tang Q, et al. Among authors: shao y. Oncogene. 2018 Jul;37(27):3617-3630. doi: 10.1038/s41388-018-0231-2. Epub 2018 Apr 3. Oncogene. 2018. PMID: 29610525

2

Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.

Shao YW, Wood GA, Lu J, Tang QL, Liu J, Molyneux S, Chen Y, Fang H, Adissu H, McKee T, Waterhouse P, Khokha R. Shao YW, et al. Oncogene. 2019 Jan;38(2):291-298. doi: 10.1038/s41388-018-0444-4. Epub 2018 Aug 9. Oncogene. 2019. PMID: 30093633 Free PMC article.

3

Abnormal B-cell development in TIMP-deficient bone marrow.

Weiss A, Saw S, Aiken A, Aliar K, Shao YW, Fang H, Narala S, Shetty R, Waterhouse PD, Khokha R. Weiss A, et al. Blood Adv. 2021 Oct 26;5(20):3960-3974. doi: 10.1182/bloodadvances.2020004101. Blood Adv. 2021. PMID: 34500457 Free PMC article.

4

Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis.

Murthy A, Shao YW, Narala SR, Molyneux SD, Zúñiga-Pflücker JC, Khokha R. Murthy A, et al. Immunity. 2012 Jan 27;36(1):105-19. doi: 10.1016/j.immuni.2012.01.005. Immunity. 2012. PMID: 22284418 Free article.

5

Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.

Shimoda M, Principe S, Jackson HW, Luga V, Fang H, Molyneux SD, Shao YW, Aiken A, Waterhouse PD, Karamboulas C, Hess FM, Ohtsuka T, Okada Y, Ailles L, Ludwig A, Wrana JL, Kislinger T, Khokha R. Shimoda M, et al. Among authors: shao yw. Nat Cell Biol. 2014 Sep;16(9):889-901. doi: 10.1038/ncb3021. Epub 2014 Aug 24. Nat Cell Biol. 2014. PMID: 25150980

6

Stromal TIMP3 regulates liver lymphocyte populations and provides protection against Th1 T cell-driven autoimmune hepatitis.

Murthy A, Shao YW, Defamie V, Wedeles C, Smookler D, Khokha R. Murthy A, et al. J Immunol. 2012 Mar 15;188(6):2876-83. doi: 10.4049/jimmunol.1102199. Epub 2012 Feb 8. J Immunol. 2012. PMID: 22323541

7

Human somatic cell mutagenesis creates genetically tractable sarcomas.

Molyneux SD, Waterhouse PD, Shelton D, Shao YW, Watling CM, Tang QL, Harris IS, Dickson BC, Tharmapalan P, Sandve GK, Zhang X, Bailey SD, Berman H, Wunder JS, Izsvák Z, Lupien M, Mak TW, Khokha R. Molyneux SD, et al. Nat Genet. 2014 Sep;46(9):964-72. doi: 10.1038/ng.3065. Epub 2014 Aug 17. Nat Genet. 2014. PMID: 25129143

8

Author Correction: Human somatic cell mutagenesis creates genetically tractable sarcomas.

Molyneux SD, Waterhouse PD, Shelton D, Shao YW, Watling CM, Tang QL, Harris IS, Dickson BC, Tharmapalan P, Sandve GK, Zhang X, Bailey SD, Berman H, Wunder JS, Izsvák Z, Lupien M, Mak TW, Khokha R. Molyneux SD, et al. Nat Genet. 2020 Apr;52(4):464. doi: 10.1038/s41588-020-0589-2. Nat Genet. 2020. PMID: 32094913

9

IGAMT: Privacy-Preserving Electronic Health Record Synthesization with Heterogeneity and Irregularity.

Wang W, Tang P, Lou J, Shao Y, Waller L, Ko YA, Xiong L. Wang W, et al. Among authors: shao y. Proc AAAI Conf Artif Intell. 2024;38(14):15634-15643. doi: 10.1609/aaai.v38i14.29491. Epub 2024 Mar 24. Proc AAAI Conf Artif Intell. 2024. PMID: 39619768 Free PMC article.

10

Hepatic SIRT6 protects against cholestatic liver disease primarily via inhibiting bile acid synthesis.

Zhang W, Wang J, Yang L, Shao Y, Peng H, Jiang L, Sheng L. Zhang W, et al. Among authors: shao y. J Biomed Res. 2024 Nov 25:1-17. doi: 10.7555/JBR.38.20240172. Online ahead of print. J Biomed Res. 2024. PMID: 39618181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,499 results

Search Page

Filters